Clinical outcomes and mortality in peritoneal dialysis patients: A 10-year retrospective analysis in a single center

Clinical Nephrology

Volumn 80, Issue 4, 2013, Pages 270-279

  Unsal, Abdulkadir ^a   Koc, Yener ^a   Basturk, Taner ^a   Sakaci, Tamer ^a   Ahbap, Elbis ^a   Sinangil, Ayse ^a   Budak, Sennur Kose ^a   Sevinc, Mustafa ^a   Kara, Ekrem ^a   Doner, Baris ^a  

^a Sisli Etfal Research and Educational Hospital   (Turkey)

Author keywords

Peritoneal dialysis; Peritonitis; Survival

Indexed keywords

PARATHYROID HORMONE; SERUM ALBUMIN;

ADULT; ARTICLE; CAUSE OF DEATH; DEMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INFECTIOUS COMPLICATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC DISEASE; SYSTOLIC BLOOD PRESSURE; TURKEY (REPUBLIC); ULTRAFILTRATION;

ADULT; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDIES; TURKEY;

EID: 84884918417     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107711     Document Type: Article

References (50)

1. Shih YC, Guo A, Just PM, Mujais S. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int. 2005; 68: 319-329.
2. Berlanga JR, Marrón B, Reyero A, Caramelo C, Ortiz A. Peritoneal dialysis retardation of progression of advanced renal failure. Perit Dial Int. 2002; 22: 239-242.
3. Gokal R, Figueras M, Ollé A, Rovira J, Badia X. Outcomes in peritoneal dialysis and haemodialysis - a comparative assessment of survival and quality of life. Nephrol Dial Transplant. 1999; 14 (Suppl 6): 24-30.
4. Heaf JG, Løkkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant. 2002; 17: 112-117.
5. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-Analysis. Peritoneal Membrane Transport, Mortality, and Technique Failure in Peritoneal Dialysis J Am Soc Nephrol. 2006; 17: 2591-2598.
6. Gamba G, Mejía JL, Saldívar S, Peña JC, Correa- Rotter R. Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron. 1993; 65: 23-27.
7. Cueto-Manzano AM, Quintana-Piña E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int. 2001; 21: 148-153.
8. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P. Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis. 1995; 26: 209-219.
9. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, Ma JZ. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1999; 34: 1065-1074.
10. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D; The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol. 1998; 9: 1285-1292.
11. Johnson JG, Gore SM, Firth J. The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: a systematic quantitative overview of the literature. Nephrol Dial Transplant. 1999; 14: 2156-2164.
12. Sipahioglu MH, Aybal A, Unal A, Tokgoz B, Oymak O, Utas C. Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years' experience in a single center. Perit Dial Int. 2008; 28: 238-245.
13. Shiao CC, Kao TW, Hung KY, Chen YC, Wu MS, Chu TS, Wu KD, Tsai TJ. Seven-year follow-up of peritoneal dialysis patients in Taiwan. Perit Dial Int. 2009; 29: 450-457.
14. Chung SH, Heimbürger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005; 20: 1207-1213.
15. Fang W, Qian J, Lin A, Rowaie F, Ni Z, Yao Q, Bargman JM, Oreopoulos DG. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre. Nephrol Dial Transplant. 2008; 23: 4021-4028.
16. Gloor HJ. 20 years of peritoneal dialysis in a midsized Swiss hospital. Swiss Med Wkly. 2003; 133: 619-624.
17. Kawaguchi Y, Hasegawa T, Kubo H, Yamamoto H, Nakayama M, Shigematsu T. Current issues of continuous ambulatory peritoneal dialysis. Artif Organs. 1995; 19: 1204-1209.
18. Kuan Y, Hossain M, Surman J, El Nahas AM, Haylor J. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant. 2005; 20: 2394-2401.
19. DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997; 30: 204-212.
20. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, Kang SW, Choi KH, Han DS, Lee HY. Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Perit Dial Int. 2007; 27: 432-440.
21. Lai KN, Lo WK. Optimal peritoneal dialysis for patients from Hong Kong. Perit Dial Int. 1999; 19 (Suppl 3): S26-S31, discussion S32-S34.
22. Lo WK, Jiang Y, Cheng SW, Cheng IKP. Survival of CAPD patients in a center using three two-liter exchanges as standard regime. Perit Dial Int. 1996; 16 (Suppl 1): S163-S166.
23. Utas C; Turkish Multicenter Peritoneal Dialysis Study Group. Patient and technique survival on CAPD in Turkey. Perit Dial Int. 2001; 21: 602-606.
24. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis. 2007; 49 (Suppl 1): A6-7, S1-296.
25. Verger C, Ryckelynck JP, Duman M, Veniez G, Lobbedez T, Boulanger E, Moranne O. French peritoneal dialysis registry (RDPLF): outline and main results. Kidney Int Suppl. 2006; 103: S12-S20.
26. Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, Jager KJ, Homel P, Augustijn H, de Charro FT, Collart F, Erek E, Finne P, Garcia-Garcia G, Grönhagen-Riska C, Ioannidis GA, Ivis F, Leivestad T, Løkkegaard H, Lopot F et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol. 2006; 17: 3510-3519.
27. van Dijk PC, Zwinderman AH, Dekker FW, Schön S, Stel VS, Finne P, Jager KJ. Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int. 2007; 71: 53-59.
28. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Ertürk S, Duman N, Karatan O, Ertug AE. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001; 60: 767-776.
29. Liberek T, Renke M, Skonieczny B, Kotewicz K, Kowalewska J, Chmielewski M, Kot J, Lichodziejewska-Niemierko M, Rutkowski B. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis. Nephrol Dial Transplant. 2009; 24: 2889-2894.
30. Lameire N, Van Biesen W, Vanholder R. The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int. 2000; 20 (Suppl 2): S134-S141.
31. Lobbedez T, Crand A, Le Roy F, Landru I, Quéré C, Ryckelynck JP. [Transfer from chronic haemodialysis to peritoneal dialysis]. Nephrol Ther. 2005; 1: 38-43.
32. Guo A, Mujais S. Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney Int Suppl. 2003; 64 (s88): S3-S12.
33. Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol. 2000; 11: 116-125.
34. Zhang X, Han F, He Q, Huang H, Yin X, Ge J, Chen J. Outcomes and risk factors for mortality after transfer from hemodialysis to peritoneal dialysis in uremic patients. Perit Dial Int. 2008; 28: 313-314.
35. Lameire NH. The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron. 1997; 77: 13-28.
36. Hedbäck G, Odén A. Increased risk of death from primary hyperparathyroidism - an update. Eur J Clin Invest. 1998; 28: 271-276.
37. Nilsson IL, Yin L, Lundgren E et al. Clinical presentation of primary hyperparathyroidism in Europe - nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res. 2002; 17 (Suppl 2): 68-74.
38. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15: 2208-2218.
39. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008; 52: 519-530.
40. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005; 67: 1179-1187.
41. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT; Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis. 2005; 46: 925-932.
42. Avram MM, Mittman N, Myint MM, Fein P. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis. 2001; 38: 1351-1357.
43. Guh JY, Chen HC, Chuang HY, Huang SC, Chien LC, Lai YH. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis. 2002; 39: 1245-1254.
44. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol. 1996; 7: 2176-2182.
45. Choi P, Nemati E, Banerjee A, Preston E, Levy J, Brown E. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis. 2004; 43: 103-111.
46. Pérez Fontan M, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005; 25: 274-284.
47. Culleton BF, Hemmelgarn BR. Is chronic kidney disease a cardiovascular disease risk factor? Semin Dial. 2003; 16: 95-100.
48. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis?. Kidney Int. 1998; 54: 2207-2217.
49. Szeto CC, Law MC, Wong TY, Leung CB, Li PK. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study. Am J Kidney Dis. 2001; 37: 329-336.
50. Wu CH, Huang CC, Huang JY, Wu MS, Leu ML. High flux peritoneal membrane is a risk factor in survival of CAPD treatment. Adv Perit Dial. 1996; 12: 105-109.